Apimeds Pharmaceuticals US, Inc (APUS) は上場企業です ヘルスケア セクターの Drug Manufacturers - Specialty & Generic 業界で事業展開. 本社所在地は Hopewell, NJ, アメリカ. 現CEOは Youngjik Cho.
APUS を有する IPO日 2025-05-09, 2 名の正社員, に上場 American Stock Excha, 時価総額 $2.36M.
Apimeds Pharmaceuticals US, Inc. operates as a clinical stage biopharmaceutical company in the United States. It researches, develops, manufactures, commercializes, and sells Apitox, an active pharmaceutical ingredient for the treatment of inflammation and pain management symptoms associated with osteoarthritis and multiple sclerosis. The company was incorporated in 2020 and is based in Hopewell, New Jersey. Apimeds Pharmaceuticals US, Inc. is a subsidiary of Api Meds, Inc.
